Patients losing 15-20% of body weight typically see 15-25 mmHg systolic reductions over 6-12 months, though some see changes earlier
Info on taking extra virgin olive oil as a supplement in pill form
For patients with established cardiovascular disease requiring evidence-based risk reduction, semaglutide 2.4 mg is the evidence-supported choice until tirzepatide's CVOT reports
Our team specializes in GLP-1 therapy, hormone optimization, IV treatments, and holistic support
Summer months with higher humidity and sweat can introduce irritants at the injection site
Frailty in individuals may include at least three of the following symptoms: unintentional weight loss, exhaustion (poor endurance), weakness (low grip strength), slowness, and physical inactivity (115)